We are live on ! Find out more
ELOX

Eloxx Pharmaceuticals, Inc. Common Stock
ELOX

Delisted

ELOX was delisted on the 13th of October, 2023.

Back to rankings

1 hedge funds and large institutions have $43 invested in Eloxx Pharmaceuticals, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

31% less capital invested

Capital invested by funds: $62 → $43 (-$19)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
OPTFSNA
1
Old Point Trust & Financial Services N A
Virginia
$43 – – –

ELOX Hedge Fund Activity: Q2 2024 in Review

1 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) for Q2 2024, worth a combined $43 — down 31% from $62 a quarter earlier.

Fund positioning in ELOX was balanced in Q2 2024: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) as of Q2 2024, unchanged from Q1 2024.
  • Funds reported $43 of Eloxx Pharmaceuticals, Inc. Common Stock stock for Q2 2024, down 31% quarter-over-quarter.
  • 0 funds opened new Eloxx Pharmaceuticals, Inc. Common Stock positions in Q2 2024 and 0 closed out.

Based on aggregated 13F filings for Q2 2024.